§
Luxuse
Patent Intelligence
Sign In
Patent US6858026B2 successfully refreshed from Google Patents.
← Back to Patent Explorer
US6858026B2 Expired / Lapsed US ⏱️ 0.0 years remaining

Methods and devices for ablation

Assignee: St Jude Medical Atrial Fibrillation Division Inc
•
Filing: 2001-12-05
•
Granted: 2005-02-22
•
Expires: 2021-12-05
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract An ablating device has a cover which holds an interface material such as a gel. The cover contains the interface material during initial placement of the device. The ablating device may also have a removable tip or a membrane filled with fluid. In still another aspect, the ablating device may be submerged in liquid during operation.

Inventors

  • 👤 John W. Sliwa, Jr.
  • 👤 Matthias Vaska
  • 👤 Jonathan L. Podmore
  • 👤 Roxanne L. Richman
  • 👤 Scott C. Anderson
  • 👤 Gerard Champsaur
  • 👤 John E. Crowe

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 22:18
CPC Classifications
A; A61; A61B; A61B18/00; A61B17/00; A61B17/22; A61B17/22004; A61B17/22012; A61B17/2202; A61B17/225; A61B17/2251; A61B18/02; A61B18/04; A61B18/12; A61B18/14; A61B18/1402; A61B18/1482; A61N; A61N1/00; A61N1/02; A61N1/04; A61N1/06; A61N7/00; A61N7/02; A61B18/148; A61B18/1492; A61B18/18; A61B18/20; A61B17/00234; A61B2017/00238; A61B2017/00243; A61B2017/00247; A61B2017/00252; A61B2017/00292; A61B2017/003; A61B2017/22072; A61B2017/22074; A61B2017/22077; A61B2017/2253; A61B17/34; A61B17/3417; A61B2017/3419; A61B2018/00005; A61B2018/00011; A61B2018/00023; A61B2018/00053; A61B2018/0016; A61B2018/00214; A61B2018/0022; A61B2018/00232; A61B2018/0025; A61B2018/00261; A61B2018/00273; A61B2018/00279; A61B2018/00285; A61B2018/00291; A61B2018/00315; A61B2018/00345; A61B2018/00351; A61B2018/00363; A61B2018/00392; A61B2018/00571; A61B2018/00577; A61B2018/00636; A61B2018/00642; A61B2018/00654; A61B2018/00773; A61B2018/00791; A61B2018/00797; A61B2018/00839; A61B2018/00898; A61B2018/00982; A61B18/1206; A61B2018/1213; A61B2018/1405; A61B2018/142; A61B2018/1467; A61B2018/147; A61B2018/1472; A61B90/00; A61B90/36; A61B90/361; A61B2090/3614; A61B90/37; A61B2090/378; A61B2090/3782; A61B90/39; A61B2090/3937; A61B2090/395; A61B2218/00; A61B2218/001; A61B2218/002; A61B2218/007; A61B34/00; A61B34/20; A61B5/00; A61B5/24; A61B5/25; A61B5/279; A61B5/28; A61B5/283; A61B5/287; A61N1/05; A61N1/056; A61N1/18; A61N1/32; A61N1/36; A61N1/362; A61N1/3629

Claims Analysis

Total Claims: 6
Claim 1
Independent Claim 101 words
A system for ablating tissue with ultrasound energy, comprising: a plurality of ablating elements which each emit focused ultrasound energy; and a control system coupled to the ablating elements, the control system controlling activation of the ablating elements and programmed to automatically change the frequency of the ablating elements when ablating the same tissue structure, each ablating element being activated to ablate tissue at a first frequency for a first plurality of time periods and to ablate the same tissue at a second frequency which is a predetermined frequency different than the first frequency, for a second plurality of time periods.
Claim 2
Independent Claim 101 words
A system for ablating tissue with ultrasound energy, comprising: a plurality of ablating elements which each emit focused ultrasound energy; and a control system coupled to the ablating elements, the control system controlling activation of the ablating elements and programmed to automatically change the frequency of the ablating elements when ablating the same tissue structure, each ablating element being activated to ablate tissue at a first frequency for a first plurality of time periods and to ablate the same tissue at a second frequency which is a predetermined frequency different than the first frequency, for a second plurality of time periods.
Claim 3
Dependent Claim 27 words
The system of claim 1 , wherein: the control system is adapted to move a focus of the ultrasound energy relative to the tissue structure being ablated.
Claim 4
Dependent Claim 24 words
The system of claim 2 , wherein: the control system moves the focus closer to a near surface of the tissue structure being ablated.
Claim 5
Dependent Claim 28 words
The method of claim 1 , wherein: the control system includes means for assessing the adequacy of contact between the ablating elements and the tissue structure being ablated.
Claim 6
Dependent Claim 18 words
The method of claim 2 , wherein: the assessing means is carried out by measuring an electrical impedance.

References Cited (Backward Citations)

US3862627A Cited
GB2094636A Cited
US5080102A Cited
US4736749A Cited
US4917095A Cited
US4872346A Cited
US5231995A Cited
US4802475A Cited
US4815470A Cited
US5588432A Cited
US5147355A Cited
US5108390A Cited
US5224943A Cited
US4936281A Cited
US5334181A Cited
US5269291A Cited
US5324255A Cited
US5447509A Cited
US5465717A Cited
US5433708A Cited
US5450843A Cited
US5254116A Cited
US5520682A Cited
US5353783A Cited
US5354258A Cited
US5323781A Cited
US5222501A Cited
US5730704A Cited
US5263493A Cited
US5555883A Cited
US5871525A Cited
US5423807A Cited
US5281215A Cited
US5443463A Cited
US5713942A Cited
US5443470A Cited
US5562720A Cited
US5277201A Cited
US5295484A Cited
US5578007A Cited
US5324284A Cited
US5500012A Cited
US5435308A Cited
US5687737A Cited
US5676693A Cited
US5656029A Cited
US5658278A Cited
US5423811A Cited
US5697927A Cited
US5478330A Cited
US5348554A Cited
US5469853A Cited
US5452733A Cited
US6161543A Cited
US5571215A Cited
US5735290A Cited
US5797960A Cited
US5571088A Cited
US5630837A Cited
US5487757A Cited
US5545200A Cited
US5928191A Cited
US5385148A Cited
US5921982A Cited
US5718701A Cited
US5405376A Cited
US5431649A Cited
US5437651A Cited
US5396887A Cited
US5607462A Cited
US5496312A Cited
US5400783A Cited
US5582609A Cited
WO1995010318A1 Cited
WO1995010321A1 Cited
US5575810A Cited
US5637090A Cited
US5871523A Cited
US5549661A Cited
WO1995010319A1 Cited
WO1995010978A1 Cited
US5497774A Cited
US5575766A Cited
US5427119A Cited
US5879296A Cited
US5536267A Cited
US6471698B1 Cited
US5487385A Cited
US5687723A Cited
US5921924A Cited
US6430426B2 Cited
US5730127A Cited
WO1995015115A1 Cited
US5643197A Cited
WO1995017222A1 Cited
US5840030A Cited
US5462545A Cited
US6238347B1 Cited
GB2289510A Cited
US5560362A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 2008-02-22 2008-08-23 2009-02-22 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2012-02-22 2012-08-23 2013-02-22 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2016-02-22 2016-08-23 2017-02-22 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag